Actively Recruiting
Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study
Led by M.D. Anderson Cancer Center · Updated on 2026-01-05
20
Participants Needed
1
Research Sites
102 weeks
Total Duration
On this page
Sponsors
M
M.D. Anderson Cancer Center
Lead Sponsor
A
Averitas Pharma, Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
To learn if topical capsaicin can help relieve pain from CIPN and improve gait (the pattern of walking) in patients.
CONDITIONS
Official Title
Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with chronic (over 90 days) chemotherapy-induced peripheral neuropathy pain in the lower extremities from specific chemotherapy drugs
- Baseline pain rating of 4 or higher on a 0-10 scale
- Age 18 years or older
- Completed chemotherapy within the last year
You will not qualify if you...
- Cognitive dysfunction
- Recent history (less than 6 months) of drug or alcohol abuse
- Open skin lesions or current antibiotic treatment for local or systemic infection
- Allergies to capsaicin or adhesives
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
MD Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
S
Saba Javed, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here